Dr Shezad Malik Law Firm has offices based in Fort Worth and Dallas and represents people who have suffered catastrophic and serious personal injuries including wrongful death, caused by the negligence or recklessness of others. We specialize in Personal Injury trial litigation and focus our energy and efforts on those we represent.
Endo’s American Medical Systems Inc. unit reported that it’s settling about 20,000 law suit product liability injury claims over the medical devices, which include the Perigee, Apogee and Elevate implants. Endo, a medical device company based in Ireland, is still exposed to at least 5,000 injury claims against AMS, including some that have been consolidated for pretrial proceedings in West Virginia.
Thousands of injured women have filed Ethicon Gynecare mesh product liability lawsuits for transvaginal repair, pelvic organ prolapse (POP) and female stress urinary incontinence (SUI) damage symptoms after the mesh surgeries.
The Ethicon Gynecare pelvic mesh and bladder sling products have been under fire for causing severe and debilitating injuries when the mesh erodes through the vagina, causing serious infections and the need for revision surgeries.
The U.S. Food and Drug Administration today issued two proposed orders to address the health risks associated with surgical mesh used for transvaginal repair of pelvic organ prolapse (POP). If finalized, the orders would reclassify surgical mesh for transvaginal POP from a moderate-risk device (class II) to a high-risk device (class III) and require manufacturers to submit a premarket approval (PMA) application for the agency to evaluate safety and effectiveness.
The Denmark-based Coloplast agreed in January to resolve about 400 suits over the plastic mesh implants which are designed to support internal organs. The settlement is said to provide an average payment of about $40,000 for each claimant.
Thousands of Ethicon Vaginal Mesh Claims
As a Texas Vaginal Mesh attorney, and Dallas medical doctor, we are reporting this important potential transvaginal mesh settlement breakthrough. According to sources, C.R. Bard Inc., and other makers of vaginal-mesh implants, are in advanced talks to settle thousands of vaginal mesh product liability lawsuits.
Bard, Endo Health Solutions Inc. the parent of AMS, Boston Scientific Corp., Coloplast and Cook Medical Inc. manufacturers making vaginal mesh devices to treat pelvic organ prolapse (POP) and treat stress urinary incontinence (SUI) in talks about settling all suits.
Johnson & Johnson, which also faces suits over the vaginal mesh devices, isn’t involved in the talks.
Transvaginal mesh injury lawsuits are consolidated and coordinated in 6 individual multidistrict litigations (MDLs) established in the federal court system. These injury claims against vaginal mesh manufacturers have now become the largest pending litigation in the U.S.
30,000 Active Mesh Lawsuits and Climbing
There are more than 30,000 complaints filed in U.S. District Courts over injuries with transvaginal mesh and bladder sling products. These medical devices have been used for treatment of pelvic organ prolapse (POP) and female stress urinary incontinence (SUI).
As a Texas Transvaginal mesh attorney and medical doctor, I am providing details on this latest medical research. According to new published research, transvaginal mesh placement provides no benefits when used for pelvic organ prolapse repair. In a study published in the Obstetrics and Gynecology journal, researchers found that the use of vaginal mesh does not increase good outcome for surgical prolapse repair when compared to more traditional treatments.
Georgetown University researchers halted the study due to the high rate of serious injuries associated with use of vaginal mesh. The study involved 65 women, 33 of whom received vaginal mesh to treat pelvic organ prolapse (POP) and 32 who underwent traditional vaginal prolapse surgery.
The women were followed for three years and the program stopped early because of a 15.6% mesh exposure rate, where the mesh eroded into the vagina.
Georgetown University researchers halted the study due to the high rate of serious injuries associated with use of vaginal mesh. The study involved 65 women, 33 of whom received vaginal mesh to treat pelvic organ prolapse (POP) and 32 who underwent traditional vaginal prolapse surgery.
The women were followed for three years and the program stopped early because of a 15.6% mesh exposure rate, where the mesh eroded into the vagina.
Bard agreed to pay an undisclosed sum to resolve Melanie Virgil’s claims that Bard’s Avaulta Plus insert caused urinary problems. Virgil’s case had been set for a Sept. 23 trial in state court in Atlantic City.
According to the filings, the 56-year-old woman said she needed three surgeries to address urinary problems created by the insert.
Dallas Fort Worth Injury Lawyer Blog